Make your money go further for just 25p per day

PREMIUM

CRISPR: one of the most important inventions of the century?

15/01/2021 · CRISPR Therapeutics (CRSP)  · GlaxoSmithKline (GSK)  · Novartis (NOVN) 

Investment Ideas Mega trends US

CRISPR image source Wikimedia

CRISPR is up there with electricity and fire. It stands for clustered regulated interspaced short palindromic repeats. In combination with the Cas9 protein, this is technology that exists in nature but can now be applied by humans to edit DNA deliberately. It could change the world, but how can private investors benefit from CRISPR/cas9, how can you invest in it?


The discovery of scissors is not something we hear much about; some research suggests you can trace their origin back to Italy around 400BC, other researchers believe they were invented in Ancient Egypt. There is, however, no mystery concerning the point when we learned how to make scissors for cutting DNA. In 2012, Emmanuelle Charpentier, Jennifer Doudna and other researchers published a paper entitled:"A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity." One assumes that the Italian who used…

Continue reading our content…

Gain access to all our excellent content for just £90 per year, that’s just 25p per day for financial freedom.
  • Unlimited access to our market-beating portfolios
  • In-depth coverage of many of the world’s great companies
  • Unique insights from our top research team
Register FREE for access to limited content.
  • Company and markets insights
  • Sponsored content
  • Podcasts

Previous article Next article

Have your say

Log in or register to view or add comments.

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on CRISPR Therapeutics

An immense opportunity

30/08/2022 · Portfolio

CRISPR Therapeutics’ therapy for sickle cell disease could be available next year; this is incredibly exciting…


Mega-Trends: A troubling 2021 opens opportunities for recovery

11/02/2022 · Portfolio

Sign-up to our free email updates

SIGN UP